ArticleDiscover oncology2025

FOXP3 as a prognostic marker and therapeutic target in immunogenic cell death modulation for clear cell renal cell carcinoma.

Jian Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.